HOUSE OF REPRESENTATIVES

THE THIRTY-THIRD LEGISLATURE

REGULAR SESSION OF 2025

 

COMMITTEE ON HEALTH

Rep. Gregg Takayama, Chair

Rep. Sue L. Keohokapu-Lee Loy, Vice Chair

 

Rep. Terez Amato

Rep. Jenna Takenouchi

Rep. Cory M. Chun

Rep. David Alcos III

Rep. Lisa Marten

Rep. Diamond Garcia

Rep. Ikaika Olds

 

 

 

NOTICE OF HEARING

 

DATE:

Friday, April 11, 2025

TIME:

10:00AM

PLACE:

VIA VIDEOCONFERENCE

Conference Room 329

State Capitol

415 South Beretania Street

 

 

 

Click here to submit testimony and to testify remotely or in person.

 

A live stream link of all House Standing Committee meetings will be available online

shortly before the scheduled start time.

 

Click here for the live stream of this meeting via YouTube.

 

 

 

A G E N D A

 

SCR 8, SD1

(SSCR1360)

Status

REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

 

 

HLT, FIN

SCR 10, SD2

(SSCR1592)

Status

URGING THE ADMINISTRATOR OF THE STATE HEALTH PLANNING AND DEVELOPMENT AGENCY TO ESTABLISH A WORKING GROUP ON HEALTH INSURANCE REFORM TO PROVIDE RECOMMENDATIONS FOR REDUCING THE IMPACT OF PRIOR AUTHORIZATION REQUIREMENTS ON THE TIMELY DELIVERY OF HEALTH CARE IN THE STATE.

 

 

HLT, FIN

SCR 16, SD1

(SSCR1543)

Status

REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A TASK FORCE TO IDENTIFY AND DEVELOP MINIMUM PROFESSIONAL STANDARDS FOR COMMUNITY HEALTH WORKER TRAINING PROGRAMS.

 

 

HLT, FIN

SCR 69, SD1

(SSCR1537)

Status

REQUESTING THE ADMINISTRATOR OF THE STATE HEALTH PLANNING AND DEVELOPMENT AGENCY TO CONVENE A PHARMACY BENEFIT MANAGER WORKING GROUP TO DETERMINE THE BEST POLICIES TO REFORM PHARMACY BENEFIT MANAGER PRACTICES IN THE STATE TO ENSURE TRANSPARENCY AND FAIRNESS FOR CONSUMERS AND IN THE PHARMACEUTICAL SECTOR, LOWER DRUG COSTS FOR PATIENT CONSUMERS, AND INCREASE ACCESS TO HEALTH CARE.

 

 

HLT, CPC

SCR 70, SD1

(SSCR1596)

Status

REQUESTING THE DIRECTOR OF COMMERCE AND CONSUMER AFFAIRS TO ESTABLISH AND CONVENE A PHARMACY REIMBURSEMENT WORKING GROUP TO EXPLORE AND PROPOSE LEGISLATION FOR THE 2026 LEGISLATIVE SESSION.

 

 

HLT, CPC

SCR 86, SD1

(SSCR1555)

Status

REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE AN AEROMEDICAL SERVICES WORKING GROUP.

 

 

HLT, FIN

SCR 118, SD1

(SSCR1557)

Status

REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A WORKING GROUP TO ASSESS THE FEASIBILITY OF ALLOWING BUSINESS OWNERS IN THE STATE TO UTILIZE FILTERED WATER COLLECTED BY WATER CATCHMENT SYSTEMS FOR BUSINESS ACTIVITIES.

 

 

HLT, FIN

SCR 120, SD1

(SSCR1361)

Status

REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATORY HEALTH INSURANCE COVERAGE FOR CONTINUOUS GLUCOSE MONITORS.

 

 

HLT, FIN

SCR 194, SD1

(SSCR1541)

Status

REQUESTING THE DEPARTMENT OF HEALTH TO ENCOURAGE REDUCTIONS IN THE USE OF DISPOSABLE SURGICAL EQUIPMENT AND ADOPTION OF SUSTAINABLE PRACTICES IN THE PROVISION OF HEALTH CARE SERVICES FOLLOWING EXAMPLES SET BY CALIFORNIA AND JAPAN.

 

 

HLT, EEP

 

 

 

 

DECISION MAKING TO FOLLOW

 

Persons wishing to offer comments should submit testimony at least 24 hours prior to the hearing.  Testimony received after this time will be stamped late and left to the discretion of the chair to consider.  While every effort will be made to incorporate all testimony received, materials received on the day of the hearing or improperly identified or directed, may not be processed.

 

Testimony submitted will be placed on the legislative website.  This public posting of testimony on the website should be considered when including personal information in your testimony.

 

The chair may institute a per-testifier time limit.

 

Committees meeting in the morning must adjourn prior to the day's Floor Session.  Therefore, due to time constraints, not all testifiers may be provided an opportunity to offer verbal comments.  However, written submissions will be considered by the committee.

 

Please refrain from profanity or uncivil behavior.  Violations may result in ejection from the hearing without the ability to rejoin.

 

For remote testifiers, the House will not be responsible for bad connections on the testifier's end.

 

For general help navigating the committee hearing process, please contact the Public Access Room at (808) 587-0478 or par@capitol.hawaii.gov.

 

The livestream and/or cable TV broadcast of this meeting will include closed captioning.  If you need an auxiliary aid/service or other accommodation (including oral, written, or ASL interpretive services) or are unable to submit testimony via the website due to a disability, please contact the committee clerk at 808-586-6120 Requests made as early as possible have a greater likelihood of being fulfilled.

 

Click here for a complete list of House Guidelines for remote testimony.

 

FOR AMENDED NOTICES:  Measures that have been deleted are stricken through and measures that have been added are bolded.

 

For more information, please contact the Committee Clerk at (808) 586-6120.

 

 

 

 

 

________________________________________

Rep. Gregg Takayama

Chair